Role of Nitric Oxide in Cardiovascular Adaptation to Intermittent Hypoxia
- 1 April 2006
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 231 (4) , 343-365
Abstract
Hypoxia is one of the most frequently encountered stresses in health and disease. The duration, frequency, and severity of hypoxic episodes are critical factors determining whether hypoxia is beneficial or harmful. Adaptation to intermittent hypoxia has been demonstrated to confer cardiovascular protection against more severe and sustained hypoxia, and, moreover, to protect against other stresses, including ischemia. Thus, the direct and cross protective effects of adaptation to intermittent hypoxia have been used for treatment and prevention of a variety of diseases and to increase efficiency of exercise training. Evidence is mounting that nitric oxide (NO) plays a central role in these adaptive mechanisms. NO-dependent protective mechanisms activated by intermittent hypoxia include stimulation of NO synthesis as well as restriction of NO overproduction. In addition, alternative, nonenzymic sources of NO and negative feedback of NO synthesis are important factors in optimizing NO concentrations. The adaptive enhancement of NO synthesis and/or availability activates or increases expression of other protective factors, including heat shock proteins, antioxidants and prostaglandins, making the protection more robust and sustained. Understanding the role of NO in mechanisms of adaptation to hypoxia will support development of therapies to prevent and treat hypoxic or ischemic damage to organs and cells and to increase adaptive capabilities of the organism.Keywords
This publication has 249 references indexed in Scilit:
- Effect of Sildenafil on Reperfusion Function, Infarct Size, and Cyclic Nucleotide Levels in the Isolated Rat Heart ModelCardiovascular Drugs and Therapy, 2005
- Oxidative stress in the systemic and cellular responses to intermittent hypoxiaBiological Chemistry, 2004
- HIF-1α-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathwayBiochemical and Biophysical Research Communications, 2002
- Hypoxia‐induced upregulation of eNOS gene expression is redox‐sensitive: A comparison between hypoxia and inhibitors of cell metabolismJournal of Cellular Physiology, 2001
- Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth MuscleJournal of Biological Chemistry, 2000
- Delayed protection of the heart against ischaemiaTrends in Pharmacological Sciences, 1995
- Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats.Stroke, 1993
- Inhibition of Nitric Oxide Limits Infarct Size in the in Situ Rabbit HeartBiochemical and Biophysical Research Communications, 1993
- Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.Hypertension, 1992
- NG-Monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shockBiochemical and Biophysical Research Communications, 1991